Sinisa Dovat

Hematology | Oncology
500 University Dr
Hershey, PA 17033

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications

Lineage-specific CK2α deletion reshapes the transcriptome of hematopoietic stem cells toward an immune-primed state.

Lineage-specific CK2α deletion reshapes the transcriptome of hematopoietic stem cells toward an immune-primed state.

Journal: bioRxiv : the preprint server for biology
Published: April 27, 2026

Establishment of Patient-Derived Organoids for Pediatric Cancer Research.

Establishment of Patient-Derived Organoids for Pediatric Cancer Research.

Journal: Cancers
Published: April 09, 2026

CK2 inhibitor, CX-4945, enhances BH3 priming and promotes apoptosis of venetoclax-resistant AML by targeting antiapoptotic proteins.

CK2 inhibitor, CX-4945, enhances BH3 priming and promotes apoptosis of venetoclax-resistant AML by targeting antiapoptotic proteins.

Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026

Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.

Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.

Journal: Oncology reviews
Published: December 03, 2025

An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.

An Overview of the Mechanisms of HPV-Induced Cervical Cancer: The Role of Kinase Targets in Pathogenesis and Drug Resistance.

Journal: Cancers
Published: November 06, 2025

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia.

Journal: Haematologica
Published: August 25, 2025

CK2α Deletion in the Hematopoietic Compartment Shows a Mild Alteration in Terminally Differentiated Cells and the Expansion of Stem Cells.

CK2α Deletion in the Hematopoietic Compartment Shows a Mild Alteration in Terminally Differentiated Cells and the Expansion of Stem Cells.

Journal: Cells
Published: May 09, 2025

From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies.

From Deworming to Cancer Therapy: Benzimidazoles in Hematological Malignancies.

Journal: Cancers
Published: August 16, 2024

Correction: Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.

Correction: Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia.

Journal: PloS one
Published: July 24, 2024

Upregulation of nuclear protein Hemgn by transcriptional repressor Gfi1 through repressing PU.1 contributes to the anti-apoptotic activity of Gfi1.

Upregulation of nuclear protein Hemgn by transcriptional repressor Gfi1 through repressing PU.1 contributes to the anti-apoptotic activity of Gfi1.

Journal: The Journal of biological chemistry
Published: July 17, 2024

Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.

Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia.

Journal: Leukemia
Published: May 22, 2024

New precision medicine weapons for targeted treatment of high-risk B-cell precursor acute lymphoblastic leukemia.

New precision medicine weapons for targeted treatment of high-risk B-cell precursor acute lymphoblastic leukemia.

Journal: Haematologica
Published: April 21, 2024
Showing 1-12 of 84

Last Updated: 09/26/2026